150 related articles for article (PubMed ID: 8449358)
1. Metabolism and function of brain kynurenines.
Schwarcz R
Biochem Soc Trans; 1993 Feb; 21(1):77-82. PubMed ID: 8449358
[No Abstract] [Full Text] [Related]
2. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
[TBL] [Abstract][Full Text] [Related]
3. Basic mechanisms of kynurenine actions in the central nervous system.
Stone TW; MacGregor DG; Smith RA; Jones P; Behan WM; Graham DI
Adv Exp Med Biol; 1996; 398():195-201. PubMed ID: 8906266
[No Abstract] [Full Text] [Related]
4. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.
Saito K; Markey SP; Heyes MP
Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184
[TBL] [Abstract][Full Text] [Related]
5. Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities.
Schwarcz R; Pellicciari R
J Pharmacol Exp Ther; 2002 Oct; 303(1):1-10. PubMed ID: 12235226
[TBL] [Abstract][Full Text] [Related]
6. Manipulation with kynurenines: a possible tool for treating neurodegenerative diseases?
Vecsei L; Plangar I; Szalardy L
Expert Rev Clin Pharmacol; 2012 Jul; 5(4):351-3. PubMed ID: 22943114
[No Abstract] [Full Text] [Related]
7. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
[TBL] [Abstract][Full Text] [Related]
8. Tryptophan metabolites and brain disorders.
Stone TW; Mackay GM; Forrest CM; Clark CJ; Darlington LG
Clin Chem Lab Med; 2003 Jul; 41(7):852-9. PubMed ID: 12940508
[TBL] [Abstract][Full Text] [Related]
9. Kynurenine pathway in depression: A systematic review and meta-analysis.
Ogyu K; Kubo K; Noda Y; Iwata Y; Tsugawa S; Omura Y; Wada M; Tarumi R; Plitman E; Moriguchi S; Miyazaki T; Uchida H; Graff-Guerrero A; Mimura M; Nakajima S
Neurosci Biobehav Rev; 2018 Jul; 90():16-25. PubMed ID: 29608993
[TBL] [Abstract][Full Text] [Related]
10. Kynurenines in the CNS: from endogenous obscurity to therapeutic importance.
Stone TW
Prog Neurobiol; 2001 Jun; 64(2):185-218. PubMed ID: 11240212
[TBL] [Abstract][Full Text] [Related]
11. Neuropharmacology of quinolinic and kynurenic acids.
Stone TW
Pharmacol Rev; 1993 Sep; 45(3):309-79. PubMed ID: 8248282
[TBL] [Abstract][Full Text] [Related]
12. Serum kynurenic acid is reduced in affective psychosis.
Wurfel BE; Drevets WC; Bliss SA; McMillin JR; Suzuki H; Ford BN; Morris HM; Teague TK; Dantzer R; Savitz JB
Transl Psychiatry; 2017 May; 7(5):e1115. PubMed ID: 28463241
[TBL] [Abstract][Full Text] [Related]
13. Repeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice.
Larsson MK; Faka A; Bhat M; Imbeault S; Goiny M; Orhan F; Oliveros A; Ståhl S; Liu XC; Choi DS; Sandberg K; Engberg G; Schwieler L; Erhardt S
Neurochem Res; 2016 Sep; 41(9):2243-55. PubMed ID: 27165635
[TBL] [Abstract][Full Text] [Related]
14. Quinolinic acid and kynurenic acid in the mammalian brain.
Schwarcz R; Du F
Adv Exp Med Biol; 1991; 294():185-99. PubMed ID: 1685291
[No Abstract] [Full Text] [Related]
15. Chronic Mild Stress Alters Kynurenine Pathways Changing the Glutamate Neurotransmission in Frontal Cortex of Rats.
Martín-Hernández D; Tendilla-Beltrán H; Madrigal JLM; García-Bueno B; Leza JC; Caso JR
Mol Neurobiol; 2019 Jan; 56(1):490-501. PubMed ID: 29725904
[TBL] [Abstract][Full Text] [Related]
16. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
[TBL] [Abstract][Full Text] [Related]
17. Possibility of Amino Acid Treatment to Prevent the Psychiatric Disorders via Modulation of the Production of Tryptophan Metabolite Kynurenic Acid.
Fukuwatari T
Nutrients; 2020 May; 12(5):. PubMed ID: 32414200
[TBL] [Abstract][Full Text] [Related]
18. The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection.
Vamos E; Pardutz A; Klivenyi P; Toldi J; Vecsei L
J Neurol Sci; 2009 Aug; 283(1-2):21-7. PubMed ID: 19268309
[TBL] [Abstract][Full Text] [Related]
19. Hypothesis kynurenic and quinolinic acids: The main players of the kynurenine pathway and opponents in inflammatory disease.
Badawy AA
Med Hypotheses; 2018 Sep; 118():129-138. PubMed ID: 30037600
[TBL] [Abstract][Full Text] [Related]
20. Role of Kynurenine Metabolism Pathway Activation in Major Depressive Disorders.
Savitz J
Curr Top Behav Neurosci; 2017; 31():249-267. PubMed ID: 27221627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
